The current price of DRTS is $13.72 — it has increased by 3.16% since the previous close. Data as of Nov 6, 2026.
DRTS is up 3.78% over the past week, down 3.72% over the past month and up 255.44% over the past year. The price is above its 200-day moving average of $10.73.
Of the 5 analysts covering Alpha Tau Medical Ltd, 1 rates it a strong buy, 3 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Alpha Tau Medical Ltd has a market capitalization of $1.27B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Alpha Tau Medical Ltd posted a loss of $0.50 per share against an estimate of -$0.1409, missing expectations by 254.91%. Upcoming reports are listed in the earnings calendar.
Alpha Tau Medical Ltd reported revenue of $100K in its most recent quarter. Analysts had expected $144.5K.
Alpha Tau Medical Ltd has not paid any dividends over the past year.
Companies most comparable to Alpha Tau Medical Ltd include Aktis Oncology, Inc., Perspective Therapeutics, Inc. and Radiopharm Theranostics Limited.
In the latest trading session DRTS moved between $13.45 and $13.97, a range of 3.79% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Alpha Tau Medical Ltd shows a buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks DRTS has traded between $3.43 and $15.79. The current price is 13.11% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.